Funding round
Nimbus Therapeutics Series A
Nimbus Therapeutics, which works in precision small molecule drug discovery in Boston, raised $24M in a Series A round announced on 28 Jun 2011, led by Atlas Venture, SR One and Lilly Ventures. 3 firms took part, 1 of them already investors. It is Nimbus Therapeutics' second venture round on record; the one before was a Seed in Mar 2011.
$24M
Amount raised
Not disclosed
Post-money valuation
3
Investors
3 leads
Valuation
What this round says about the price
Nimbus Therapeutics did not disclose a valuation in this round. It came 3 months after Nimbus Therapeutics' Seed. It is 4.2% of the $569M Nimbus Therapeutics has raised in the venture rounds on record. Nimbus Therapeutics raised again 45 months later: a Series B round of $43M in Mar 2015.
Nimbus Therapeutics' funding rounds
Nimbus Therapeutics has 7 venture rounds on record. This one is highlighted.
- Seed 1 Mar 2011 $1.5M
- Series A this round 28 Jun 2011, led by Atlas Venture, SR One and Lilly Ventures $24M
- Series B 18 Mar 2015, led by Pfizer Venture Investments and Lightstone Ventures $43M
- Growth 14 Oct 2020, led by RA Capital $60M
- Growth 13 Jul 2021, led by BVF Partners L.P. $105M
- Growth 12 Sep 2022, led by Bain Capital Life Sciences and SV Health Investors $125M
- Growth 6 Sep 2023, led by GV, SR One and Atlas Venture $210M
Investors
Who put money in
Atlas Venture, SR One and Lilly Ventures led the round. Atlas Venture had backed Nimbus Therapeutics before.
Lead investors
- backs 43 venture-backed companies existing investor
- backs 22 venture-backed companies new investor
- Lilly Ventures new investor
Joined the board: Kent Gossett (SR One) and Steve Hall (Lilly Ventures).
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
The closest in time, other companies' Series A rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Pharmaceutical Products | 27 Mar 2012 | $13M | not disclosed | Novartis Venture Fund |
| Pharmaceutical Products | 17 Apr 2012 | $10M | not disclosed | Bessemer Venture Partners and Frazier Healthcare Partners |
| Pharmaceutical Products | 23 Apr 2012 | $2.0M | not disclosed | Wheatley MedTech Partners, L.P. and Wheatley New York Partners LP |
Sources
Where this comes from
Reported by 4 sources.
Questions
Frequently asked
How much did Nimbus Therapeutics raise in its Series A round?
Nimbus Therapeutics raised $24M in its Series A round, announced in Jun 2011.
Who led Nimbus Therapeutics' Series A round?
Atlas Venture, SR One and Lilly Ventures led it.
What was Nimbus Therapeutics' valuation at the Series A round?
It was not disclosed.
Did Nimbus Therapeutics raise again after this round?
Yes: a Series B round in Mar 2015 of $43M.